|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/551 | |
| A61K 31/7052 | |||
| A61K 31/7068 | |||
| A61K 31/706 | |||
| A61P 35/00 | |||
| A61P 35/02 |
| (11) | Number of the document | 2416781 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10713756.4 |
| Date of filing the European patent application | 2010-04-06 | |
| (97) | Date of publication of the European application | 2012-02-15 |
| (45) | Date of publication and mention of the grant of the patent | 2017-03-08 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2010/030081 |
| Date | 2010-04-06 |
| (87) | Number | WO 2010/118013 |
| Date | 2010-10-14 |
| (30) | Number | Date | Country code |
| 167117 P | 2009-04-06 | US |
| (72) |
BELYAKOV, Sergei, SG
DUVALL, Bridget, US
FERRARIS, Dana, US
HAMILTON, Gregory, US
VAAL, Mark, US
|
| (73) |
Otsuka Pharmaceutical Co., Ltd.,
2-9, Kanda Tsukasa-machi Chiyoda-ku, Tokyo 101-8535,
JP
|
| (54) | COMBINATION OF CYTIDINE-BASED ANTINEOPLASTIC DRUGS WITH CYTIDINE DEAMINASE INHIBITOR AND USE THEREOF IN THE TREATMENT OF CANCER |
| COMBINATION OF CYTIDINE-BASED ANTINEOPLASTIC DRUGS WITH CYTIDINE DEAMINASE INHIBITOR AND USE THEREOF IN THE TREATMENT OF CANCER |